Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CACIPLIQ20 for Post-surgical Scars in Mammoplasty
NCT05528328Phase 3Recruiting
- Start
- Mar 2023
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms). Primary endpoint: Global Scar Comparison Scale at 24 weeks. Started Mar 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05528328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05528328.